About Fifth Eye
Fifth Eye is a company based in Ann Arbor (United States) founded in 2017 by Jeffrey Basch and Mark Salamango was acquired by AirStrip in June 2025. Fifth Eye has raised $19.3 million across 3 funding rounds from investors including AirStrip, Arboretum Ventures and Cultivation Capital. The company has 13 employees as of December 31, 2022. Fifth Eye offers products and services including AHI System. Fifth Eye operates in a competitive market with competitors including Tricog, Ultromics, Rhythm AI, CardioLogs and Ligence, among others.
- Headquarter Ann Arbor, United States
- Employees 13 as on 31 Dec, 2022
- Founders Jeffrey Basch, Mark Salamango
-
Sectors
HealthcareTechnology
-
Phone
Locked
-
Website
Locked
-
Social
Locked
- Legal Name Fifth Eye Inc.
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Products & Services of Fifth Eye
Fifth Eye offers a comprehensive portfolio of products and services, including AHI System.
AI software that detects and predicts hemodynamic instability via ECG signals.
Funding Insights of Fifth Eye
Fifth Eye has successfully raised a total of $19.3M across 3 strategic funding rounds. The most recent funding activity was a Series A round of $5.4 million completed in December 2021. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
Investors in Fifth Eye
Fifth Eye has secured backing from 4 investors, including venture fund investors. Prominent investors backing the company include AirStrip, Arboretum Ventures and Cultivation Capital.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Healthcare venture capital investments are made by Arboretum Ventures.
|
Locked | Locked | Locked | |
|
Early-stage tech companies are funded by this venture capital firm.
|
Locked | Locked | Locked | |
|
Investments are provided to early-stage technology startups in Michigan.
|
Locked | Locked | Locked |
Investor details for Fifth Eye
Investor domains, locations, round participation, and complete history require an active premium plan.
- Investor domains
- Investor locations
- Funding rounds
- Participation history
Verified entity values are shown only after access is granted.
Investments & Acquisitions by Fifth Eye
Investment portfolio details for Fifth Eye
Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.
- Portfolio identities
- Transaction dates
- Round details
- Investment values
Verified entity values are shown only after access is granted.
Financial Statements - Fifth Eye
Detailed financials for Fifth Eye
Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.
- Historical revenue
- Profit trends
- Statement rows
- Financial ratios
Verified entity values are shown only after access is granted.
Fifth Eye Comparisons
Peer comparison for Fifth Eye
Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.
- Named peers
- Headcount comparison
- Funding comparison
- Operating benchmarks
Verified entity values are shown only after access is granted.
Competitors of Fifth Eye
Fifth Eye operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Tricog, Ultromics, Rhythm AI, CardioLogs and Ligence, among others.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| Locked | Locked | Locked |
AI-powered cardiac diagnostic solutions are provided for care pathways.
|
|
| Locked | Locked | Locked |
AI-powered echocardiography analysis for cardiovascular disease detection is provided.
|
|
| Locked | Locked | Locked |
AI-based platform for cardiac disease diagnosis is provided.
|
|
| Locked | Locked | Locked |
Automated ECG interpretation is used for cardiovascular screening.
|
|
| Locked | Locked | Locked |
AI-based 2D echocardiography is provided for heart ultrasound analysis.
|
Detailed competitors of Fifth Eye
Competitor domains, locations, full profiles, and operating metrics require an active premium plan.
- Domains and locations
- Full company profiles
- Operating metrics
- Competitive positioning
Verified entity values are shown only after access is granted.
Latest news on Fifth Eye
Complete news archive for Fifth Eye
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Fifth Eye
Fifth Eye was founded in 2017 and raised its 1st funding round 1 year after it was founded.
Fifth Eye is headquartered in Ann Arbor, United States. It is registered at Ann Arbor, Michigan, United States.
Fifth Eye is a funded company, having raised a total of $19.3M across 3 funding rounds to date.
As of Dec 31, 2022, the latest employee count at Fifth Eye is 13.
Fifth Eye was founded in 2017 in Ann Arbor, United States, within the healthcare analytics sector. An analytics platform is developed to address hemodynamic instability through machine learning analysis of ECG vitals. Real-time insights into cardiac health are delivered, enabling detection of potential issues. Predictive analytics for acute hemodynamic instability (AHI) are integrated to support clinical decision-making and treatment strategies for patients.
Fifth Eye's top competitors include Tricog, Ultromics and VentriJect.
Fifth Eye offers AHI System.
Fifth Eye has 4 investors. Key investors include AirStrip, Arboretum Ventures, Cultivation Capital, and Invest Michigan.